Data from the Co‐IP assay suggested that UCHL1 may bind the SET domain of EZH2 (Figure 5G,H) and immunofluorescence experiments revealed co‐localization of EZH2 and UCHL1 in NB cells (Figure S1D). The gene discussed is EZH2; the disease is neuroblastoma.